STAT+: Pharmalittle: WTO head says Covid vaccine IP talks are nearing agreement; RSV is the next big target for vaccine makers
And so, another working will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. We have a somewhat busy agenda this time around. We plan to host one or two short people as we observe some ancient traditions and, of course, we expect to promenade extensively with the official mascot. There are also naps to be had. And what about you? This is a fine time to enjoy the great outdoors. You could tidy up around the castle or plan a summer getaway. Perhaps you simply want to hit the pause button and take stock. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …
The head of the World Trade Organization says negotiations on an intellectual property proposal for Covid-19 vaccines are ongoing between the four parties, and they are seeking to agree on the final terms, Reuters reports. Since the draft compromise emerged a month ago, pressure from advocacy groups has been rising for the parties — the U.S., the European Union, India, and South Africa — to walk away from the deal, because it is too narrowly focused on vaccines. “People are saying the text is now being rejected. It is not true,” Director-General Ngozi Okonjo-Iweala said. “They are still trying to iron out the last things. It’s just the last few tweaks,” she said, without elaborating.
Continue to STAT+ to read the full story…
